Analysis of tauopathies with transgenic mice

Mike Hutton, Jada Lewis, Dennis W Dickson, Shu Hui Yen, Eileen McGowan

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Intraneuronal filamentous inclusions composed of the microtubule-associated protein tau are a feature of several neurodegenerative diseases (including Alzheimer's disease) known as tauopathies. A pivotal finding was the identification in 1998 of mutations in tau associated with frontotemporal dementia with parkinsonism linked to chromosome 17. This demonstrated that tau dysfunction is sufficient to cause neurodegeneration, and indicated that tau is likely to play a crucial role in the pathogenesis of other tauopathies. However, the mechanism by which tau filamentous lesions form and their role in neurodegeneration remains uncertain. Recent progress in the development of transgenic mouse models of human tauopathy is allowing these questions to be addressed.

Original languageEnglish (US)
Pages (from-to)467-470
Number of pages4
JournalTrends in Molecular Medicine
Volume7
Issue number10
DOIs
StatePublished - 2001

Fingerprint

Tauopathies
Transgenic Mice
Frontotemporal Dementia
Chromosomes, Human, Pair 17
Microtubule-Associated Proteins
Neurodegenerative Diseases
Alzheimer Disease
Mutation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Analysis of tauopathies with transgenic mice. / Hutton, Mike; Lewis, Jada; Dickson, Dennis W; Yen, Shu Hui; McGowan, Eileen.

In: Trends in Molecular Medicine, Vol. 7, No. 10, 2001, p. 467-470.

Research output: Contribution to journalArticle

Hutton, Mike ; Lewis, Jada ; Dickson, Dennis W ; Yen, Shu Hui ; McGowan, Eileen. / Analysis of tauopathies with transgenic mice. In: Trends in Molecular Medicine. 2001 ; Vol. 7, No. 10. pp. 467-470.
@article{79ff8487fc754287bd2154ac6a2099c1,
title = "Analysis of tauopathies with transgenic mice",
abstract = "Intraneuronal filamentous inclusions composed of the microtubule-associated protein tau are a feature of several neurodegenerative diseases (including Alzheimer's disease) known as tauopathies. A pivotal finding was the identification in 1998 of mutations in tau associated with frontotemporal dementia with parkinsonism linked to chromosome 17. This demonstrated that tau dysfunction is sufficient to cause neurodegeneration, and indicated that tau is likely to play a crucial role in the pathogenesis of other tauopathies. However, the mechanism by which tau filamentous lesions form and their role in neurodegeneration remains uncertain. Recent progress in the development of transgenic mouse models of human tauopathy is allowing these questions to be addressed.",
author = "Mike Hutton and Jada Lewis and Dickson, {Dennis W} and Yen, {Shu Hui} and Eileen McGowan",
year = "2001",
doi = "10.1016/S1471-4914(01)02123-2",
language = "English (US)",
volume = "7",
pages = "467--470",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "10",

}

TY - JOUR

T1 - Analysis of tauopathies with transgenic mice

AU - Hutton, Mike

AU - Lewis, Jada

AU - Dickson, Dennis W

AU - Yen, Shu Hui

AU - McGowan, Eileen

PY - 2001

Y1 - 2001

N2 - Intraneuronal filamentous inclusions composed of the microtubule-associated protein tau are a feature of several neurodegenerative diseases (including Alzheimer's disease) known as tauopathies. A pivotal finding was the identification in 1998 of mutations in tau associated with frontotemporal dementia with parkinsonism linked to chromosome 17. This demonstrated that tau dysfunction is sufficient to cause neurodegeneration, and indicated that tau is likely to play a crucial role in the pathogenesis of other tauopathies. However, the mechanism by which tau filamentous lesions form and their role in neurodegeneration remains uncertain. Recent progress in the development of transgenic mouse models of human tauopathy is allowing these questions to be addressed.

AB - Intraneuronal filamentous inclusions composed of the microtubule-associated protein tau are a feature of several neurodegenerative diseases (including Alzheimer's disease) known as tauopathies. A pivotal finding was the identification in 1998 of mutations in tau associated with frontotemporal dementia with parkinsonism linked to chromosome 17. This demonstrated that tau dysfunction is sufficient to cause neurodegeneration, and indicated that tau is likely to play a crucial role in the pathogenesis of other tauopathies. However, the mechanism by which tau filamentous lesions form and their role in neurodegeneration remains uncertain. Recent progress in the development of transgenic mouse models of human tauopathy is allowing these questions to be addressed.

UR - http://www.scopus.com/inward/record.url?scp=0034788203&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034788203&partnerID=8YFLogxK

U2 - 10.1016/S1471-4914(01)02123-2

DO - 10.1016/S1471-4914(01)02123-2

M3 - Article

VL - 7

SP - 467

EP - 470

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 10

ER -